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Supervised Sorting
Training Computers to Classify Toxicants
A new application of an existing computer learning system can
improve the use of gene expression profiles to classify toxicants to
which an animal has been exposed, according to work published
this month by Guido Steiner and colleagues at the pharmaceuti-
cal company F. Hoffmann–La Roche [EHP 112:1236–1248].
The authors write that these investigations could help separate
transcriptional changes that are of relevance for the mode of
toxicity from mere bystander effects—coincidences that have lit-
tle predictive value and that can be amplified by other computa-
tional approaches. 
Predicting how any given toxicant will affect an organism is pos-
sible if similar compounds produce comparable changes in gene
expression. Identifying useful panels of genes whose expression pro-
files change predictably in response to toxicants is a major goal
for predictive toxicology.
Finding effective ways to
sort, interpret, and antici-
pate changes in expression
is critical for moving these
observations into a practical
understanding of toxic
effects. Background “noise”
and the natural variation
between experimental ani-
mals as well as compound-
related characteristics in
pharmacologic and toxic
action complicate matters
by creating variability in
the analyzed data.
Other approaches to
sorting gene expression data
for toxicogenomics have
included several “unsuper-
vised” methods, in which
modeling programs search
for patterns within data
and generate models of
toxicity without being
given any hint as to what
kinds of expression pat-
terns the researchers expect to find. The strength of this approach
is that it allows for unbiased data exploration. On the other hand,
it is not guaranteed to primarily retrieve information that is rele-
vant for addressing the scientific problem at hand. 
The approach reported by Steiner and colleagues is different.
This group has applied a “supervised” method to toxicogenomics
using what are called support vector machines (SVM). SVMs—
which are computational tools, not physical machines—take
advantage of additional data in the form of pathology and serum
measurements that are fed into the algorithm. These data are used
to assign gene expression profiles to specific modes of toxicity. The
SVM identifies the most relevant information for discriminating
among the given samples. After learning from a “training set” of
biological samples, the model should be able to correctly classify
new samples exposed to compounds that the SVM has not
encountered before. Therefore, the method has to construct classi-
fication rules that still work with data different from the initial
training data.
Steiner and colleagues used an SVM to find classification
rules connecting patterns of gene expression in response to a
series of known or suspected hepatotoxicants. The predictive
genes were picked using another computational tool, recursive
feature elimination (RFE), which is an integral part of SVM cre-
ation. In RFE, the computer produces a ranking of all the fea-
tures that it uses to define a fingerprint—in this case, the expression
profiles of each gene on a microarray. Then it calculates how
much each feature contributed to that fingerprint. Uninformative
or redundant features tend to be eliminated in an iterative process
as less relevant, allowing refinement of the fingerprint’s definition
to include only its most reliable features. These compact signa-
tures can then be used to identify the class of toxicant to which
an animal has been exposed. 
In testing the system, the authors looked at 28 hepatotoxi-
cants and 3 nonhepatotoxic compounds. Looking in rats, they
laid out gene expression profiles, clinical chemistry, hematology,
and histopathology for the different chemicals at various time
points following exposure. In addition to discriminating between
compounds that are hepa-
totoxic and ones that are
not, their predictive mod-
els were in most cases also
able to predict what kind
of toxicant the animals
had been exposed to—a
direct-acting one that
causes damage itself, a
cholestatic one that inter-
feres with bile, or a steatot-
ic one that drives buildup
of fat in the liver. By the
same strategy, the SVM
was able to recognize ani-
mals that had been exposed
to the hepatotoxicant
galactosamine but failed to
respond with the typical
necrosis and inflammation
of the liver. 
Pharmacologic activity
can alter gene expression
in the liver without neces-
sarily signaling hepatotox-
icity. The SVM correctly
identified 3 tested phar-
macoactive compounds as nonhepatotoxic and also correctly
identified 3 hepatotoxic compounds whose mechanisms of toxici-
ty were not included in the data sets used to train the machines.
In two out of three cases, the SVM was able to correctly identify
the general mode by which these compounds were toxic. 
The models were extended to unknown rat strains, as well.
After identifying expression profiles in Wistar rats induced by sev-
eral peroxisome proliferator–activated receptor (PPAR) agonists,
the SVM was used to look at data for the livers of Sprague-Dawley
rats exposed to another PPAR agonist, WY14643. The SVM was
able to correctly recognize both Sprague-Dawley rats exposed to
WY14643 and the control animals, and could predict that treat-
ment with WY14643 would stimulate peroxisome proliferation. 
So far, the work has dealt predominantly with toxicant con-
centrations that yield substantial and largely unambiguous effects.
To optimize the system to more accurately predict subtle changes,
toxicologists and bioinformaticians will need both further
improvements in computational methods and a larger database
linking compounds and their effects on gene expression.
–Victoria McGovern
Old computers learn new tricks. Computational tools known as support vector
machines discern relevant gene expression data from samples and apply what they
learn in order to classify new compounds.Science Selections
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It’s All in the Interaction
Quantitating Gene Networks
Toxicologists who use microarrays hope to uncover relationships
that link gene expression data to signal transduction pathways,
gene networks that are often used to describe the sequence of bio-
chemical events controlling cellular function. The large quantities
of data generated by microarray studies generally are examined
qualitatively—for example, by comparing whether one gene is
turned on relative to another. These qualitative relationships,
however, fail to describe how genes in a network influence each
other. Still in their infancy are tools that quantitate the complex
relationships within gene networks more comprehensively than
simple correlations between pairs of genes. Now, for the first
time, researchers describe a new quantitative statistical technique
that assesses the interactions of genes in a network [EHP
112:1217–1224]. 
The team, led by Hiroyoshi Toyoshiba of the NIEHS
Laboratory of Computational Biology and Risk Assessment, cre-
ated a statistical software program that verifies concurrently that
the expression of one gene is linked to the expression of several
others. The first proof-of-concept demonstration evaluated genes
that are directly responsive to tetrachlorodibenzo-p-dioxin
(TCDD; a ubiquitous environmental pollutant and known
human carcinogen) and their effect on the retinoic acid signal
transduction pathway. 
Signal transduction pathways respond to different environmen-
tal conditions; they are like molecular circuits that detect and inte-
grate diverse external signals to alter gene transcription. This
results in changes in enzyme activities as well as the production of
abnormal levels of proteins, which further results in changes in
biochemical processes. Alterations in signal transduction pathways
can lead to cancer and other disorders. 
Toyoshiba and colleagues had earlier identified genes that are
altered in lung airway epithelial cells after exposure to TCDD.
Starting with microarrays composed of 2,000 genes that are known
to be expressed in response to environmental toxicants, the
researchers had identified 11 genes that responded significantly to
TCDD in two different lung cell lines. These genes appeared to be
involved in the effects of TCDD on the retinoic acid signal trans-
duction pathway. 
The researchers constructed a hypothetical model of the
retinoic acid signal transduction pathway that describes how the
11 genes interrelate. Based on published reports on retinoic acid
metabolism, the model postulated that dietary vitamin A (retinol)
is converted first to retinal and then to retinoic acid by alcohol
dehydrogenases and, possibly, by cytochrome P450 enzymes. Once
synthesized, retinoic acid enters the cell nucleus. There, it binds
retinoic acid receptor beta, which, in turn, alters the expression of
genes that may play a role in tumor formation. The hypothetical
model included genes that produce three alcohol dehydrogenases,
a cytochrome P450 enzyme, retinoic acid binding proteins and
receptors, and four nuclear proteins. 
Following exposure to three concentrations of TCDD, the
expression levels of the 11 genes were calculated relative to unex-
posed controls. Statistical methods were applied to these data to
test the hypothetical linkages between TCDD-responsive genes
and the retinoic acid signal transduction pathway. These tests con-
firmed strong linkages between the genes included in the hypo-
thetical model. 
Epidemiological studies show a strong association between
TCDD and lung cancer; the model offers a potential explanation for
how TCDD damages the
lungs. TCDD appears to acti-
vate genes associated with the
synthesis of retinoic acid,
which—through the retinoic
acid signal transduction path-
way—turns on nuclear genes
that promote cell proliferation
and carcinogenesis. Scientists
can focus future experiments
on particular genes directly
related to TCDD-induced
tumor progression. 
The new statistical tool
makes it possible to under-
stand biological pathways in
cells, tissues, organs, and
whole organisms. It can be
expanded to include other
relevant data, such as protein
levels in cells. These data can
be combined with pharma-
cological models to present a
true systems biology approach
to quantifying risks from
exposure to xenobiotics such
as TCDD, suggest the
authors. Other researchers can
obtain the statistical software
by contacting laboratory
director Christopher Portier
at portier@niehs.nih.gov.
–Carol Potera
Notating networks. A new statistical package goes beyond qualifying interactions between a single pair of genes
to describe how multiple genes within a network influence expression.